Anbio Biotechnology Announces Pricing of Initial Public Offering
The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or ...
Saladax Biomedical Inc. Appoints Regulatory and Quality Expert Ms. Stacie Geffner-Atiya as Director of Regulatory and Quality
Ms. Geffner-Atiya holds a Bachelor of Science degree from the State University of New York at Brockport. In her new role, she will oversee regulatory compliance, quality assurance, and global ...